Jacobs Levy Equity Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,322
| Closed | -$48K | – | 1008 |
|
|
2024
Q1 | $48K | Sell |
5,322
-91,762
| -95% | -$827K | ﹤0.01% | 926 |
|
|
2023
Q4 | $920K | Buy |
97,084
+66,226
| +215% | +$627K | ﹤0.01% | 736 |
|
|
2023
Q3 | $367K | Sell |
30,858
-29,469
| -49% | -$351K | ﹤0.01% | 854 |
|
|
2023
Q2 | $1.48M | Buy |
60,327
+29,065
| +93% | +$712K | 0.01% | 628 |
|
|
2023
Q1 | $978K | Buy |
31,262
+21,417
| +218% | +$670K | 0.01% | 700 |
|
|
2022
Q4 | $693K | Buy |
9,845
+1,908
| +24% | +$134K | ﹤0.01% | 734 |
|
|
2022
Q3 | $683K | Buy |
+7,937
| New | +$683K | 0.01% | 783 |
|
|
2020
Q2 | – | Sell |
-1,526
| Closed | -$67K | – | 1104 |
|
|
2020
Q1 | $67K | Sell |
1,526
-7,484
| -83% | -$329K | ﹤0.01% | 970 |
|
|
2019
Q4 | $361K | Buy |
9,010
+80
| +0.9% | +$3.21K | ﹤0.01% | 827 |
|
|
2019
Q3 | $293K | Buy |
+8,930
| New | +$293K | ﹤0.01% | 780 |
|